相关实验视频

Updated: Jul 5, 2025

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

在自发性脑内出血后,与莱维西拉使用相关的结果

Mary Stewart Leatherwood¹, Leslie A Hamilton^1,2, Jacob Barber²

¹Department of Pharmacy, The University of Tennessee Medical Center, Knoxville, TN, USA.

The Neurohospitalist

|January 18, 2024

概括

预防性 levetiracetam 并没有降低自发性脑内出血 (ICH) 患者的发作发生率. 这项研究发现,两组之间的发作,重症监护室停留时间或住院停留时间没有显著差异.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.

背景情况:

自发性脑内出血 (ICH) 可能导致发作.
预防性抗发作药物有时被认为是ICH患者.

研究的目的:

评估在接受预防性 levetiracetam 的自发性脑内出血 (ICH) 患者中发作的发生率.
评估 levetiracetam 对ICH患者在没有先前史的发作发生率和医院结局的影响.

主要方法:

追溯队列研究设计.
包括自发性ICH患者,但不包括有先前发作障碍或服用家庭抗药物的患者.
在接受 levetiracetam 和未接受 levetiracetam 的患者之间比较了发病率,ICU 停留时间 (LOS) 和医院 LOS.

主要成果:

在 levetiracetam (4.8%) 和没有 levetiracetam (1.4%) 组 (P = .32) 之间没有观察到发作发生率的统计学上显著差异.
在两组中都发现了类似的ICU LOS (2天 vs 2天) 和医院 LOS (6天 vs 6天) 的中位数.
在不良事件发生率上没有发现显著差异.

结论:

这些发现不支持在自发性脑内出血后的患者中常规使用 levetiracetam 预防.
可能需要进一步的研究来澄清预防性抗发作药物在ICH管理中的作用.

关键词:

脑内出血脑内出血莱维泰拉塞坦 ( levetiracetam) 的使用情况发作预防预防性治疗

更多相关视频

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...